Professor | Bao-Rui Liu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Bao-Rui Liu
Language ability	Chinese, English
Province	Jiangsu

Upload Avatar (500 x 500)

Name

Bao-Rui Liu

Language ability

Chinese, English

Province

Jiangsu

University/Lab Affiliation and Title	Nanjing University
Faculty	Life Sciences
Academic Background & Achievements	1981.9~1986.7 Bachelor of Medicine: Fourth Military Medical University 1986.9~1989.7 Master of Medicine: Fourth Military Medical University 1992.9~1995.7 Doctor of Medicine: Fourth Military Medical University
Work Experience	1989-2001 - Fourth Military Medical University Xijing Hospital - Role not specified 1998-1999 - MD Anderson Cancer Center, USA - Postdoctoral 2001.3- - Nanjing Drum Tower Hospital, Nanjing University Medical School - Director of Oncology Center 2003.5- - Nanjing University Clinical Oncology Institute - Director 2015.11- - Nanjing Drum Tower Hospital, Nanjing University Medical School - Vice President
Awards	2019: Jiangsu Province Science and Technology First Prize; New discoveries and translational research in precision medicine for gastric cancer based on molecular markers 2016: Ministry of Education Science and Technology Progress Second Prize; Establishment of gelatinase-targeted smart nano-drug system and its efficacy and mechanism in gastric cancer 2019: Jiangsu Medical Science First Prize; Precision individualized treatment of gastric cancer 2015: Jiangsu Province Science and Technology Second Prize; Basic clinical research on new targeted nano-drug delivery systems for gastric cancer 2012: Jiangsu Province Science and Technology Second Prize; Screening and evaluation of biomarkers for individualized treatment of gastric cancer 2011: Chinese Medical Science and Technology Second Prize; Clinical translational research on individualized treatment of gastric cancer with platinum and taxane drugs 2012: Chinese Anti-Cancer Association Science and Technology Second Prize; Clinical translational research on individualized treatment of gastric cancer with platinum and taxane drugs 2010: Chinese Anti-Cancer Association Science and Technology Second Prize; Clinical basic research on hyperthermic chemotherapy and hyperthermic targeted therapy for malignant tumors 2015: Jiangsu Medical Science Second Prize; Basic clinical research on new targeted nano-drug delivery systems for gastric cancer 2011: Jiangsu Medical Science Second Prize; Clinical translational research on individualized treatment of gastric cancer with platinum and taxane drugs 2008: Jiangsu Province Science and Technology Progress Third Prize; Clinical basic research on hyperthermic chemotherapy and hyperthermic targeted therapy for malignant tumors 2015: Chinese Medical Science and Technology Third Prize; Basic clinical research on new targeted nano-drug delivery systems for gastric cancer 2008: Nanjing City Science and Technology Progress Second Prize; Clinical basic research on hyperthermic chemotherapy and hyperthermic targeted therapy for malignant tumors 2007: Jiangsu Province Medical Introduction of New Technology First Prize; Extraction and amplification technology of ERCC1 gene from paraffin-embedded gastric cancer tissue and its application in platinum-based chemotherapy 2009: Jiangsu Province Medical Introduction of New Technology Second Prize; Intraperitoneal hyperthermic perfusion cisplatin deep radiofrequency hyperthermia combined with OLF regimen for advanced gastric cancer 2003: Jiangsu Province Medical Introduction of New Technology Second Prize; Establishment and preliminary application of high-dose sequential chemotherapy technology supported by hematopoietic stem cells 2010: Jiangsu Traditional Chinese Medicine Science and Technology Third Prize; Screening of anti-tumor Chinese medicine and isolation, extraction, and mechanism research of effective monomers of Forsythia suspensa 2004: Nanjing City Health and Health New Technology Second Prize; Establishment and application of experimental technology for preparing sufficient CIK cells from 50ml peripheral blood

University/Lab Affiliation and Title

Nanjing University

Faculty

Life Sciences

Academic Background & Achievements

1981.9~1986.7 Bachelor of Medicine: Fourth Military Medical University
1986.9~1989.7 Master of Medicine: Fourth Military Medical University
1992.9~1995.7 Doctor of Medicine: Fourth Military Medical University

Work Experience

1989-2001 - Fourth Military Medical University Xijing Hospital - Role not specified
1998-1999 - MD Anderson Cancer Center, USA - Postdoctoral
2001.3- - Nanjing Drum Tower Hospital, Nanjing University Medical School - Director of Oncology Center
2003.5- - Nanjing University Clinical Oncology Institute - Director
2015.11- - Nanjing Drum Tower Hospital, Nanjing University Medical School - Vice President

Awards

2019: Jiangsu Province Science and Technology First Prize; New discoveries and translational research in precision medicine for gastric cancer based on molecular markers
2016: Ministry of Education Science and Technology Progress Second Prize; Establishment of gelatinase-targeted smart nano-drug system and its efficacy and mechanism in gastric cancer
2019: Jiangsu Medical Science First Prize; Precision individualized treatment of gastric cancer
2015: Jiangsu Province Science and Technology Second Prize; Basic clinical research on new targeted nano-drug delivery systems for gastric cancer
2012: Jiangsu Province Science and Technology Second Prize; Screening and evaluation of biomarkers for individualized treatment of gastric cancer
2011: Chinese Medical Science and Technology Second Prize; Clinical translational research on individualized treatment of gastric cancer with platinum and taxane drugs
2012: Chinese Anti-Cancer Association Science and Technology Second Prize; Clinical translational research on individualized treatment of gastric cancer with platinum and taxane drugs
2010: Chinese Anti-Cancer Association Science and Technology Second Prize; Clinical basic research on hyperthermic chemotherapy and hyperthermic targeted therapy for malignant tumors
2015: Jiangsu Medical Science Second Prize; Basic clinical research on new targeted nano-drug delivery systems for gastric cancer
2011: Jiangsu Medical Science Second Prize; Clinical translational research on individualized treatment of gastric cancer with platinum and taxane drugs
2008: Jiangsu Province Science and Technology Progress Third Prize; Clinical basic research on hyperthermic chemotherapy and hyperthermic targeted therapy for malignant tumors
2015: Chinese Medical Science and Technology Third Prize; Basic clinical research on new targeted nano-drug delivery systems for gastric cancer
2008: Nanjing City Science and Technology Progress Second Prize; Clinical basic research on hyperthermic chemotherapy and hyperthermic targeted therapy for malignant tumors
2007: Jiangsu Province Medical Introduction of New Technology First Prize; Extraction and amplification technology of ERCC1 gene from paraffin-embedded gastric cancer tissue and its application in platinum-based chemotherapy
2009: Jiangsu Province Medical Introduction of New Technology Second Prize; Intraperitoneal hyperthermic perfusion cisplatin deep radiofrequency hyperthermia combined with OLF regimen for advanced gastric cancer
2003: Jiangsu Province Medical Introduction of New Technology Second Prize; Establishment and preliminary application of high-dose sequential chemotherapy technology supported by hematopoietic stem cells
2010: Jiangsu Traditional Chinese Medicine Science and Technology Third Prize; Screening of anti-tumor Chinese medicine and isolation, extraction, and mechanism research of effective monomers of Forsythia suspensa
2004: Nanjing City Health and Health New Technology Second Prize; Establishment and application of experimental technology for preparing sufficient CIK cells from 50ml peripheral blood

Areas of Focus	Individualized drug therapy for complex tumors Individualized targeted immunotherapy
Publications	In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors., Sun Z, Li R, Shen Y, Tan S, Ding N, Xu R, Wang X, Wei J, Liu B, Meng F., 2022 Bifunctional Fusion Membrane-Based Hydrogel Enhances Antitumor Potency of Autologous Cancer Vaccines by Activating Dendritic Cells., Ke Y, Zhu J, Chu Y, Cen L, Fu Y, Fan X, Shao J, Li R, Yu L, Liu B, Liu Q., 2022 Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy., Zhu J, Ke Y, Liu Q, Yang J, Liu F, Xu R, Zhou H, Chen A, Xiao J, Meng F, Yu L, Li R, Wei J, Liu B., 2022 Benefits of an immunogenic personalized neoantigen nanovaccine in patients with high-risk gastric/gastroesophageal junction cancer., Liu Q, Chu Y, Shao J, Qian H, Yang J, Sha H, Cen L, Tian M, Xu Q, Chen F, Yang Y, Wang W, Wang K, Yu L, Wei J, Liu B., 2022 In situ gelatinase-responsive and thermosensitive nanocomplex for local therapy of gastric cancer with peritoneal metastasis., Wang X, Gao J, Li C, Xu C, Li X, Meng F, Liu Q, Wang Q, Yu L, Liu B, Li R., 2022 Engineering a HemoMap Nanovaccine for Inducing Immune Responses against Melanoma., Dai H, Huang Y, Guo J, Li L, Ke Y, Cen L, Meng F, Chen X, Liu B, Qian X., 2022 Nanotechnology-Based CAR-T Strategies for Improving Efficacy and Safety of Tumor Immunotherapy., Wang X, Meng F, Yen Y, Li R, Liu B., 2021 Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation., Zhou S, Meng F, Du S, Qian H, Ding N, Sha H, Zhu M, Yu X, Wang L, Liu B, Wei J., 2021 Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors., Chen F, Zou Z, Du J, Su S, Shao J, Meng F, Yang J, Xu Q, Ding N, Yang Y, Liu Q, Wang Q, Sun Z, Zhou S, Du S, Wei J, Liu B., 2019 iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer., Ding N, Zou Z, Sha H, Su S, Qian H, Meng F, Chen F, Du S, Zhou S, Chen H, Zhang L, Yang J, Wei J, Liu B., 2019 mRNA Expression of BRCA1, PIAS1, and PIAS4 and Survival After Second-line Docetaxel in Advanced Gastric Cancer., Wei J, Costa C, Ding Y, Zou Z, Yu L, Sanchez J, Qian X, Chen H, Gimenez-C A, Meng F, Moran T, Benlloch S, Taron M, Rosell R, Liu B*., 2011

Areas of Focus

Individualized drug therapy for complex tumors
Individualized targeted immunotherapy

Publications

In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors., Sun Z, Li R, Shen Y, Tan S, Ding N, Xu R, Wang X, Wei J, Liu B*, Meng F., 2022
Bifunctional Fusion Membrane-Based Hydrogel Enhances Antitumor Potency of Autologous Cancer Vaccines by Activating Dendritic Cells., Ke Y, Zhu J, Chu Y, Cen L, Fu Y, Fan X, Shao J, Li R, Yu L, Liu B*, Liu Q., 2022
Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy., Zhu J, Ke Y, Liu Q, Yang J, Liu F, Xu R, Zhou H, Chen A, Xiao J, Meng F, Yu L, Li R, Wei J, Liu B*., 2022
Benefits of an immunogenic personalized neoantigen nanovaccine in patients with high-risk gastric/gastroesophageal junction cancer., Liu Q, Chu Y, Shao J, Qian H, Yang J, Sha H, Cen L, Tian M, Xu Q, Chen F, Yang Y, Wang W, Wang K, Yu L, Wei J, Liu B*., 2022
In situ gelatinase-responsive and thermosensitive nanocomplex for local therapy of gastric cancer with peritoneal metastasis., Wang X, Gao J, Li C, Xu C, Li X, Meng F, Liu Q, Wang Q, Yu L, Liu B*, Li R., 2022
Engineering a HemoMap Nanovaccine for Inducing Immune Responses against Melanoma., Dai H, Huang Y, Guo J, Li L, Ke Y, Cen L, Meng F, Chen X, Liu B*, Qian X., 2022
Nanotechnology-Based CAR-T Strategies for Improving Efficacy and Safety of Tumor Immunotherapy., Wang X, Meng F, Yen Y, Li R, Liu B*., 2021
Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation., Zhou S, Meng F, Du S, Qian H, Ding N, Sha H, Zhu M, Yu X, Wang L, Liu B*, Wei J., 2021
Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors., Chen F, Zou Z, Du J, Su S, Shao J, Meng F, Yang J, Xu Q, Ding N, Yang Y, Liu Q, Wang Q, Sun Z, Zhou S, Du S, Wei J, Liu B*., 2019
iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer., Ding N, Zou Z, Sha H, Su S, Qian H, Meng F, Chen F, Du S, Zhou S, Chen H, Zhang L, Yang J, Wei J, Liu B*., 2019
mRNA Expression of BRCA1, PIAS1, and PIAS4 and Survival After Second-line Docetaxel in Advanced Gastric Cancer., Wei J, Costa C, Ding Y, Zou Z, Yu L, Sanchez J, Qian X, Chen H, Gimenez-C A, Meng F, Moran T, Benlloch S, Taron M, Rosell R, Liu B*., 2011

Personalized Medicine Tumor Drug Therapy Immunotherapy Targeted Therapy Cancer Oncology Treatment Precision Medicine Biomarkers

Haiyun Wang - Tongji University

Hua Xiao - Shanghai Jiao Tong University

Yue Zhang - Shanghai Jiao Tong University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us